In this long-term, large-scale, low-cost trial, after a mean of 8.0 years of treatment and follow-up in 14,641 men, neither vitamin E nor vitamin C supplementation reduced the risk of prostate or total cancer. There was also no clear effect of either agent on other site-specific cancers. It is reassuring that there was not a clear signal of harm for either agent. These data provide no support for the use of these supplements in the prevention of cancer in middle-aged and older men. Results of the multivitamin arm of the PHS II will be forthcoming in several years.
Selenium or vitamin E, alone or in combination at the doses and formulations used, did not prevent prostate cancer in this population of relatively healthy men.
Get Clipmarks - The easiest way to email text, images and videos you find on the web.
No comments:
Post a Comment